HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haigh, P. I. Articles by Glass, E. C. Search for Related Content PubMed Articles by Haigh, P. I. Articles by Glass, E. C.

Factors Affecting Sentinel Node Localization During Preoperative Breast Lymphoscintigraphy

Joyce Eisenberg Keefer Breast Center and Division of Surgical Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica; Statistical Coordinating Unit, John Wayne Cancer Institute, and Department of Nuclear Medicine, Saint John's Health Center, Santa Monica, California

Variable success rates for identifying axillary (AX) sentinel nodes in breast cancer patients using preoperative lymphoscintigraphy have been reported. We evaluated the effects of age, weight, breast size, method of biopsy, interval after biopsy, and imaging view on the success of sentinel node identification and on the kinetics of radiopharmaceutical migration. Methods: Preoperative breast lymphoscintigraphy was performed in consecutive breast cancer patients from February 1998 to December 1998. The ipsilateral shoulder was elevated on a foam wedge and the arm was abducted and elevated overhead. Imaging using this modified oblique view of the axilla (MOVA) started immediately after peritumoral injection of Millipore-filtered ^99mTc-sulfur colloid and continued until AX sentinel nodes were identified. Anterior views were obtained after MOVA. AX, internal mammary (IM), and clavicular (CL) basins were monitored in all patients. MOVA was compared with the anterior view for sentinel node identification. Age, weight, breast size, method of biopsy, interval after biopsy, and primary tumor location were evaluated for their effects on sentinel node localization and transit times from injection to arrival at the sentinel nodes. Results: Seventy-six lymphoscintigrams were obtained for 75 patients. AX sentinel nodes were revealed in 75 (99%) cases. IM or CL sentinel nodes were found in 19 (25%) cases and were not related to tumor location; exclusive IM drainage was present in 1 (1%) case. Identification of AX sentinel nodes was equivalent with MOVA and anterior views in 18 (24%) patients, was better with MOVA in 20 (26%) patients, and was accomplished only with MOVA in 38 (50%) patients. Median transit time was 17.5 min (range, 1 min to 18 h) after injection, and larger breast size was associated with increased transit time. No effect of age, weight, biopsy method, interval from biopsy, or tumor location on transit time was found. Conclusion: Use of MOVA can improve identification of AX sentinel nodes. Although AX drainage is the predominant pattern, a tumor in any portion of the breast can drain to IM sentinel nodes. Transit time was influenced by breast size. Overall short arrival times with this technique allow sentinel lymph node dissection to be performed on the same day as lymphoscintigraphy.

Key Words: breast cancer • lymphoscintigraphy • sentinel node

Received Oct. 19, 1999; revision accepted Feb. 16, 2000.

For correspondence or reprints contact: Edwin C. Glass, MD, Nuclear Medicine Section-115, West Los Angeles VA Medical Center, 11301 Wilshire Blvd., Los Angeles, CA 90073.

This article has been cited by other articles:

				P. Bourgeois Scintigraphic Investigations of the Lymphatic System: The Influence of Injected Volume and Quantity of Labeled Colloidal Tracer J. Nucl. Med., May 1, 2007; 48(5): 693 - 695. [Abstract] [Full Text] [PDF]

				H. Tsushima, T. Takayama, T. Yamanaga, H. Kizu, Y. Shimonishi, K. Kosakai, A. Noguchi, and M. Onoguchi Usefulness of Medium-Energy Collimator for Sentinel Node Lymphoscintigraphy Imaging in Breast Cancer Patients. J. Nucl. Med. Technol., September 1, 2006; 34(3): 153 - 159. [Abstract] [Full Text] [PDF]

				B. Taback, P. Nguyen, N. Hansen, G. K. Edwards, K. Conway, and A. E. Giuliano Sentinel Lymph Node Biopsy for Local Recurrence of Breast Cancer After Breast-Conserving Therapy Ann. Surg. Oncol., August 1, 2006; 13(8): 1099 - 1104. [Abstract] [Full Text] [PDF]

				E. P. Mamounas Continuing Evolution in Breast Cancer Surgical Management J. Clin. Oncol., March 10, 2005; 23(8): 1603 - 1606. [Full Text] [PDF]

				B. R. Krynyckyi, S. Sata, I. Zolty, C. K. Kim, and K. Knesaurek Reducing Exposure from 57Co Sources During Breast Lymphoscintigraphy by Optimizing Energy Windows and Other Suggested Enhancements of Acquisition and the Display of Images J. Nucl. Med. Technol., December 1, 2004; 32(4): 198 - 205. [Abstract] [Full Text] [PDF]

				S H Kim, J Shim, C K Kim, J Machac, and B R Krynyckyi Reverse echelon node and a lymphatic ectasia in the same patient during breast lymphoscintigraphy: the importance of injection and imaging technique Br. J. Radiol., December 1, 2004; 77(924): 1053 - 1056. [Abstract] [Full Text] [PDF]

				B. R. Krynyckyi, C. K. Kim, M. R. Goyenechea, P. T. Chan, Z.-Y. Zhang, and J. Machac Clinical Breast Lymphoscintigraphy: Optimal Techniques for Performing Studies, Image Atlas, and Analysis of Images RadioGraphics, January 1, 2004; 24(1): 121 - 145. [Abstract] [Full Text] [PDF]

				B. R. Krynyckyi, H. Chun, H. H. Kim, Y. Eskandar, C. K. Kim, and J. Machac Factors Affecting Visualization Rates of Internal Mammary Sentinel Nodes During Lymphoscintigraphy J. Nucl. Med., September 1, 2003; 44(9): 1387 - 1393. [Abstract] [Full Text] [PDF]

				I. Brenot-Rossi, G. Houvenaeghel, J. Jacquemier, V.-J. Bardou, M. Martino, N. Hassan-Sebbag, and J. Pasquier Nonvisualization of Axillary Sentinel Node During Lymphoscintigraphy: Is There a Pathologic Significance in Breast Cancer? J. Nucl. Med., August 1, 2003; 44(8): 1232 - 1237. [Abstract] [Full Text] [PDF]

				V. Galimberti, P. Veronesi, P. Arnone, C. De Cicco, G. Renne, M. Intra, S. Zurrida, V. Sacchini, R. Gennari, A. Vento, et al. Stage Migration After Biopsy of Internal Mammary Chain Lymph Nodes in Breast Cancer Patients Ann. Surg. Oncol., November 1, 2002; 9(9): 924 - 928. [Abstract] [Full Text] [PDF]

				P. Shen, E. C. Glass, L. A. DiFronzo, and A. E. Giuliano Dermal Versus Intraparenchymal Lymphoscintigraphy of the Breast Ann. Surg. Oncol., April 1, 2001; 8(3): 241 - 248. [Abstract] [Full Text] [PDF]